BLT 0.00% 2.6¢ benitec biopharma limited

Ann: Half Yearly Report and Accounts, page-47

  1. 5,224 Posts.
    lightbulb Created with Sketch. 2
    A CR wasn't explicitly announced but it would have scared already shocked investors. They said they needed funding to pursue the clinical trials which will be next year. That funding may be provided by a partner.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.